Trifluoromethanesulfonic Acid

Trifluoromethanesulfonic Acid

SCHEMBL707413

CCCC[n+]1ccn(C)c1C.O=S(=O)([O-])C(F)(F)F

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 8/20 0.41
CA1 P00915 3/20 0.40
CA2 P00918 3/20 0.40
ACHE P22303 7/20 0.39
EEF2K O00418 2/20 0.32
EEF2 P13639 2/20 0.32
MEN1 O00255 1/20 0.32
PLK4 O00444 1/20 0.32
JAK2 O60674 1/20 0.32
EGFR P00533 1/20 0.32
TYK2 P29597 1/20 0.32
FLT3 P36888 1/20 0.32
BLM P54132 1/20 0.32
KMT2A Q03164 1/20 0.32
ITK Q08881 1/20 0.32
PIM2 Q9P1W9 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoromethanesulfonic Acid SCHEMBL1329120 0.94 CA1 (0.47) KCNH2CA1CA2ACHEEEF2K
Trifluoromethanesulfonic Acid SCHEMBL1329985 0.94 CA1 (0.47) KCNH2CA1CA2ACHEEEF2K
Trifluoromethanesulfonic Acid SCHEMBL1330197 0.94 CA1 (0.47) KCNH2CA1CA2ACHEEEF2K
Trifluoromethanesulfonic Acid SCHEMBL711975 0.94 CA1 (0.47) KCNH2CA1CA2ACHEEEF2K
Trifluoromethanesulfonic Acid SCHEMBL1681506 0.91 KCNH2 (0.37) KCNH2CA1CA2ACHE
Sulfuric Acid SCHEMBL4247474 0.90 CA1 (0.44) CA1CA2EEF2KEEF2MEN1
SCHEMBL358138 0.88 CA1 (0.36) KCNH2CA1CA2ACHE
SCHEMBL4247119 0.88 CA1 (0.43) CA1CA2EEF2KEEF2MEN1
Sulfuric Acid SCHEMBL21195055 0.88 CA1 (0.43) CA1CA2EEF2KEEF2MEN1
Trifluoromethanesulfonic Acid SCHEMBL25275366 0.87 CA1 (0.42) CA1CA2EEF2KEEF2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 333 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12172148-B2 Catalyst composition for selective hydrogenation with improved characteristics Sud Chemie, Inc. (US) 2024-12-24 US claimed
US-12172147-B2 Catalyst composition for selective hydrogenation with improved characteristics Sud Chemie, Inc. (US) 2024-12-24 US claimed
US-20230250251-A1 DISSOLUTION PURIFICATION AND RECOVERY FOR POLYMER RECYCLING Alliance for Energy Innovation, LLC 2023-08-10 US claimed
US-11634370-B2 Selective hydrogenation methods CLARIANT INTERNATIONAL LTD (CH) 2023-04-25 US claimed
US-11623902-B2 Selective hydrogenation methods and catalysts CLARIANT INTERNATIONAL LTD (CH) 2023-04-11 US claimed
CN-110951420-B Adhesive composition 藤森工业株式会社 2023-03-31 CN claimed
CN-115768737-A Selective hydrogenation process 科莱恩国际有限公司 2023-03-07 CN claimed
CN-115715280-A Selective hydrogenation process and catalyst 科莱恩国际有限公司 2023-02-24 CN claimed
US-11207640-B2 System and method for adjusting carbon dioxide concentration in indoor atmospheres PALO ALTO RESEARCH CENTER INCORPORATED (US) 2021-12-28 US claimed
US-20210395906-A1 ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY CUSTOMARRAY INC (US) 2021-12-23 US claimed
EP-1869061-A2 ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY Combimatrix Corporation (US) 2007-12-26 EP claimed
EP-1805206-A2 ELECTROCHEMICAL DEBLOCKING USING A HYDRAZINE DERIVATIVE Combimatrix Corporation (US) 2007-07-11 EP claimed
US-20070034513-A1 Electrochemical deblocking solution for electrochemical oligomer synthesis on an electrode array COMBIMATRIX CORPORATION 2007-02-15 US claimed
WO-2007006418-A1 IONIC-LIQUID-CONTAINING PRODUCTS FOR DYEING AND/OR BRIGHTENING KERATIN FIBRES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2007-01-18 WO claimed
WO-2006131234-A1 COSMETIC COMPOSITIONS COMPRISING IONIC LIQUIDS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2006-12-14 WO claimed
WO-2006105037-A2 ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY COMBIMATRIX CORPORATION (US) 2006-10-05 WO claimed
WO-2006031814-A2 ELECTROCHEMICAL DEBLOCKING USING A HYDRAZINE DERIVATIVE COMBIMATRIX CORPORATION (US) 2006-03-23 WO claimed
US-20060054511-A1 Electrochemical deblocking using a hydrazine derivative CUSTOMARRAY, INC. 2006-03-16 US claimed
US-20050150383-A1 Facilitated transport membranes for an alkene Hydrocarbon separation KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY 2005-07-14 US claimed
EP-1552875-A1 Facilitated transport membranes for an alkene hydrocarbon separation Korea Institute of Science and Technology (KR) 2005-07-13 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12172147-B2 Catalyst composition for selective hydrogenation with improved characteristics BET1, EP300, H1-2 KCNH2 2193/4885CA1 841/4885CA2 2397/4885
US-12172148-B2 Catalyst composition for selective hydrogenation with improved characteristics BET1, EP300, H1-2 KCNH2 2193/4885CA1 841/4885CA2 2397/4885
US-20210395906-A1 ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY DNMT1, DNASE1, DNPEP KCNH2 484/4885CA1 195/4885CA2 1004/4885
US-11634370-B2 Selective hydrogenation methods KAT8, KAT7, TDO2 KCNH2 2137/4885CA1 258/4885CA2 1838/4885
US-11623902-B2 Selective hydrogenation methods and catalysts KAT8, ITGAV, ASNS KCNH2 2186/4885CA1 1185/4885CA2 3259/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.